Page 22 - Zai Lab News Today

Zai Lab's shares benefited from positive clinical trial news.

Harbin Clinic Gastroenterology Endoscopy & GI Lab in Rome, GA has earned a 3-year renewal recognition from the American Society for Gastrointestinal Endoscopy f

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Airbnb joining the S&P 500, Manchester United to be taken off…

Company Announcement Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival at predetermined, independent interim analysisTrial results to be submitted for...

Genmab A/S and Seagen Inc. announced that the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on or after front-line therapy who received...

Seagen Inc. and Genmab A/S announced today that the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on or after front-line therapy who...

Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) and Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation. Earnings and Valuation This table compares Capricor Therapeutics […]

The Center for Drug Evaluation, of the National Medical Products Administration in China, has granted breakthrough therapy designation to repotrectinib for use in patients with advanced solid tumors harboring a NTRK gene fusion who experienced disease progression after TKI treatment.

Zai Lab Limited announced that the Center for Drug Evaluation of the National Medical Products Administration granted Breakthrough Therapy Designation for investigational repotrectinib for the...

By Sabela Ojea Shares of Zai Lab on Wednesday climbed after the biotechnology company said the Center for Drug Evaluation of China's National Medical...